((R)-1-{(S)-2-[(1-Acetyl-pyrrolidine-2-carbonyl)-amino]-propionylamino}-ethyl)-[2-((S)-3-methyl-1-phenylcarbamoyl-butylcarbamoyl)-4-phenyl-butyl]-phosphinic acid

InChIKey	`FDWJCEDPTNPQLJ-GPPFSWFQSA-N`
Compound Name	((R)-1-{(S)-2-[(1-Acetyl-pyrrolidine-2-carbonyl)-amino]-propionylamino}-ethyl)-[2-((S)-3-methyl-1-phenylcarbamoyl-butylcarbamoyl)-4-phenyl-butyl]-phosphinic acid
Canonical SMILES	`CC(=O)N1CCCC1C(=O)N[C@@H](C)C(=O)N[C@@H](C)P(=O)(O)CC(CCc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)Nc1ccccc1`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	8.21
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P08254	MMP3	Homo sapiens	Human	PF00045 PF00413 PF01471	8.2	Ki	ChEMBL;BindingDB
Q9ULZ9	MMP17	Homo sapiens	Human	PF00045 PF00413 PF01471	8.2	pIC50	TTD_MultiTarget
P18843	nadE	Escherichia coli (strain K12)	Pathogen	PF02540	8.2	pIC50	TTD_MultiTarget